Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00718497 · ClinicalTrials.gov registry record

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

A clinical trial of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, sponsored by Drexel University College of Medicine.

Completed
Registry status
25
Enrollment target
1
Study location

NCT00718497 is a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease that has completed, run by Drexel University College of Medicine. The registered enrollment target is 25 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00718497, a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, has completed, sponsored by Drexel University College of Medicine.

COMPLETED
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

New technologies are giving people with motor disabilities alternative communication and control channels. The investigators are interested in using the Cyberlink Control System as a hands free means to access a computer for people with Amyotrophic Lateral Sclerosis (ALS). The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to communicate with only the use of facial muscle, brainwave, and eye movements. The benefit of this study may be of substantial value to many people with severe motor impairment. Additionally, it is hoped that some of the study subjects may benefit by incorporating hands-free computer use into their daily lives. This study is intended to evaluate the effectiveness of the cyberlink as a tool for daily communication compared to the standard manual letter board.

Study Locations (1)

Pennsylvania

  • MDA/ALS Center of Hope - Philadelphia

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2007-08
Est. Completion 2012-05

What the Registry Record Tells You About NCT00718497

The ClinicalTrials.gov registry entry for NCT00718497 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00718497 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00718497 about?

NCT00718497 is a clinical study titled "Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population". New technologies are giving people with motor disabilities alternative communication and control channels. The investigators are interested in using the Cyberlink Control System as a hands free means to access a computer for people with Amyotrophic Lateral Sclerosis (ALS). The goal of this project i...

What is the current status of trial NCT00718497?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2007-08. Estimated completion is 2012-05.

What conditions does trial NCT00718497 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neurodegenerative Disease.

Who is sponsoring clinical trial NCT00718497?

This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00718497 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.